Magnetic resonance imaging-guided focused ultrasound ablation of uterine fibroids: Early clinical experience

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 26, Issue 4, 2008, Pages 198-205

  Mikami, Koji ^a   Murakami, Takamichi ^b   Okada, Atsuya ^c   Osuga, Keigo ^a   Tomoda, Kaname ^a   Nakamura, Hironobu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Iseikai Hospital   (Japan)

Author keywords

Focused ultrasound; Magnetic resonance imaging; Uterine fibroid

Indexed keywords

GADODIAMIDE;

ADULT; ARTICLE; BURN; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MEDICAL INSTRUMENTATION; MENSTRUATION DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; ULTRASOUND; UTERUS MYOMA;

ADULT; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRASONIC THERAPY; UTERINE NEOPLASMS;

EID: 44449158246     PISSN: 02882043     EISSN: 18625274     Source Type: Journal    
DOI: 10.1007/s11604-007-0215-6     Document Type: Article

References (23)

1. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, Colditz GA, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 1997;90:967-973.
2. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol 1990;97:285-298.
3. Benagiano G, Morini A, Primiero FM. Fibroids: overview of current and future treatment options. Br J Obstet Gynaecol 1992;99:18-22.
4. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med 1993;328:856-860.
5. Tulandi T, al-Took S. Endoscopic myomectomy: laparoscopic and hysteroscopy. Obstet Gynecol Clin North Am 1999;26:135-148.
6. Cowan BD, Sewell PE, Howard JC, Arriola RM, Robinette LG. Interventional magnetic resonance imaging cryotherapy of uterine fibroid tumors: preliminary observation. Am J Obstet Gynecol 2002;186:1183-1187.
7. Law P, Gedroyc WM, Regan L. Magnetic resonance guided percutaneous laser ablation of uterine fibroids. Lancet 1999;354:2049-2050.
8. Ravina JH, Herbreteau D, Ciaru-Vigneron N, Bouret JM, Houdart E, Aymard A, et al. Arterial embolization to treat uterine myomata. Lancet 1995;346:671-672.
9. Pelage JP, Dref OL, Soyer P, Kardache M, Dahan H, Abitbol M, et al. Fibroid-related menorrhagia: treatment with super-selective embolization of the uterine arteries and midterm follow-up. Radiology 2000;215:428-431.
10. Tempany CM, Stewart EA, McDannold N, Quade BJ, Jolesz FA, Hynynen K. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology 2003;226:897-905.
11. Stewart EA, Gedroyc WM, Tempany CM, Quade BJ, Inbar Y, Ehrenstein T, et al. Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique. Am J Obstet Gynecol 2003;189:48-54.
12. Hindley J, Gedroyc WM, Regan L, Stewart E, Tempany C, Hynynen K, et al. MR guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 2004;183:1713-1719.
13. Stewart EA, Rabinovici J, Tempany CM, Inbar Y, Regan L, Gastout B, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril 2006;85:22-29.
14. Fennessy FM, Tempany CM, McDannold NJ, Minna JS, Gina H, Gostout B, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-results of different treatment protocols. Radiology 2007;243:885-893.
15. Elizabeth KA, Neil MK, Ame NR, Robert JM. Features Influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol 2007;18:681-685.
16. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-3045.
17. Kuroda K, Chung A, Hynynen K, Jolesz FA. Calibration of water proton chemical shift with temperature for noninvasive temperature imaging during focused ultrasound surgery. J Magn Reson Imaging 1998;8:175-181.
18. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290-300.
19. Ueda H, Togashi K, Konishi I, Kataoka ML, Koyama T, Fujiwara T, et al. Unusual appearances of uterine leiomyomas: mr imaging findings and their histopathologic backgrounds. Radiographics 1999;19:131-145.
20. Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S, Mauro M, et al. The Fibroid Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005;106:1309-1318.
21. Hovsepian DM, Siskin GP, Bonn J, Cardella JF, Clark TW, Lampmann LE, et al. Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata. J Vasc Interv Radiol 2004;15:535-541.
22. Katsumori T, Nakajima K, Tokuhiro M. Gadolinium-enhanced MR imaging in the evaluation of uterine fibroids treated with uterine artery embolization AJR Am J Roentgenol 2001;177:303-307.
23. Pelage JP, Guaou NG, Jha RC, Ascher SM, Spies JB. Uterine fibroid tumors: long-term MR imaging outcome after embolization. Radiology 2004;230:803-809.